Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Frederich, Markus ^a,c   Zhang, Li ^a   Balschi, James A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BLI 247 ^*  (United States)

^c UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

31P nuclear magnetic resonance spectroscopy; Acetyl CoA carboxylase; Signal transduction

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE PHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; POTASSIUM; THREONINE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; IN VIVO STUDY; ISOLATED HEART; NONHUMAN; OXYGEN TENSION; OXYGENATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ACETYL-COA CARBOXYLASE; ADENOSINE MONOPHOSPHATE; ANIMALS; ANOXIA; CYTOSOL; ENZYME ACTIVATION; ISOENZYMES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIENZYME COMPLEXES; MYOCARDIUM; PHOSPHORUS ISOTOPES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; SERINE; SIGNAL TRANSDUCTION; THREONINE;

EID: 18044388214     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00558.2004     Document Type: Article

References (40)

1. Adams J, Chen ZP, Van Denderen BJ, Morton CJ, Parker MW, Witters LA, Stapleton D, and Kemp BE. Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci 13: 155-165, 2004.
2. Altarejos JY, Taniguchi M, Clanachan AS, and Lopaschuk GD. Myocardial ischemia differentially regulates LKB1 and an alternate 5′AMP-activated protein kinase kinase. J Biol Chem 280: 183-190, 2004.
3. Bak MI and Ingwall JS. NMR-invisible ATP in heart: fact or fiction? Am J Physiol Endocrinol Metab 262: E943-E947, 1992.
4. Balschi JA, Shen H, Madden MC, Hai JO, Bradley EL Jr, and Wolkowicz PE. Model systems for modulating the free energy of ATP hydrolysis in normoxically perfused rat hearts. J Mol Cell Cardiol 29: 3123-3133, 1997.
5. Beauloye C, Marsin AS, Bertrand L, Krause U, Hardie DG, Vanoverschelde JL, and Hue L. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts without affecting total adenine nucleotides. FEBS Lett 505: 348-352, 2001.
6. Becker LB, vanden Hoek TL, Shao ZH, Li CQ, and Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol 277: H2240-H2246, 1999.
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
8. 31P-NMR Bayesian spectral analysis of rat brain in vivo. Magn Reson Med 9: 282-287, 1989.
9. 2 sensing. J Biol Chem 275: 25130-25138, 2000.
10. 2. Biochem Biophys Res Commun 287: 92-97, 2001.
11. Corton JM, Gillespie JG, Hawley SA, and Hardie DG. 5-Aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
12. Dagher Z, Ruderman N, Tornheim K, and Ido Y. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem Biophys Res Comm 265: 112-115, 1999. Erratum: Biochem Biophys Res Commun 266: 615, 1999.
13. Dagher Z, Ruderman N, Tornheim K, and Ido Y. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem Biophys Res Comm 265: 112-115, 1999. Erratum: Biochem Biophys Res Commun 266: 615, 1999.
14. Davies SP, Helps NR, Cohen PT, and Hardie DG. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett 377: 421-425, 1995.
15. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, and Ratcliffe PJC. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54, 2001.
16. Frederich M and Balschi JA. The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J Biol Chem 277: 1928-1932, 2002.
17. Fryer LG, Parbu-Patel A, and Carling D. The anti-diabetic drugs rostglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232, 2002.
18. Hardie DG and Carling D. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997.
19. Hardie DG, Carling D, and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
20. Hardie DG, Salt IP, Hawley SA, and Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338: 717-722, 1999.
21. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, and Hardie DG. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2: 28, 2003.
22. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, and Hardie DG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887, 1996.
23. Hawley SA, Gadalla AE, Olsen GS, and Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51: 2420-2425, 2002.
24. 2+/calmodulin activates the calmodulin-dependent protein kinase 1 cascade, via three independent mechanisms. J Biol Chem 270: 27186-27191, 1995.
25. 2-regulated prolyl hydroxylation. Science 292: 468-472, 2001.
26. Kemp BE. Bateman domains and adenosine derivatives form a binding contract. J Clin Invest 113: 182-184, 2004.
27. eq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem 254: 6528-6537, 1979.
28. Nishizawa J, Nakai A, Matsuda K, Komeda M, Ban T, and Nagata K. Reactive oxygen species play an important role in the activation of heat shock factor 1 in ischemic-reperfused heart. Circulation 99: 934-941, 1999.
29. Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, and Winder WW. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol 92: 2475-2482, 2002.
30. Safer B, Smith CM, and Williamson J. Control of the transport of reducing equivalents across the mitochondrial membrane in perfused rat heart. J Mol Cell Cardiol 2: 111-124, 1971.
31. Schulz H. Inhibitors of fatty acid oxidation. Life Sci 40: 1443-1449, 1987.
32. Scott JW, Hawley SA, Green KA, Anis M, Stewart G, Scullion GA, Norman DG, and Hardie DG. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 113: 274-284, 2004.
33. Semenza GL. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64: 993-998, 2002.
34. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, and Kemp BE. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271: 611-614, 1996.
35. Stein SC, Woods A, Jones NA, Davison MD, and Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345: 437-443, 2000.
36. Tian R, Musi N, D'Agostino J, Hirshman MF, and Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104: 1664-1669, 2001.
37. Warden SM, Richardson C, O'Donnell J, Stepleton D, Kemp BE, and Witters LA. Posttranslational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J 354: 275-283, 2001.
38. Woods A, Cheung PC, Smith FC, Davison MD, Scott J, Beri RK, and Carling D. Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J Biol Chem 271: 10282-10290, 1996.
39. Woods A, Vertommen D, Neumann D, Turk R, Bayliss J, Schlattner U, Wallimann T, Carling D, and Rider MH. Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J Biol Chem 278: 28434-28442, 2003.
40. Zou MH, Hou XY, Shi CM, Kirkpatick S, Liu F, Goldman MH, and Cohen RA. Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J Biol Chem 278: 34003-34010, 2003.